10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Latest (Page 7)
Combo Therapy Shows Promise in Advanced Endometrial Cancer Trial
Phase 2 trial evaluates PARP inhibitor and antiangiogenic agent in recurrent endometrial cancer.
Acyclovir Prophylaxis Slashes Mucositis Risk in Stem Cell Transplant Patients
Study shows acyclovir prophylaxis significantly reduces oral mucositis in autologous stem cell transplants.
Sintilimab Boosts Survival in Advanced Gastric Cancer: ORIENT-16 Trial Results
Immunotherapy drug sintilimab improves survival in advanced gastric cancer when added to chemotherapy.
Immunotherapy Breakthrough: Toripalimab Boosts Survival in Nasopharyngeal Cancer
Toripalimab plus chemotherapy significantly improves survival in recurrent/metastatic nasopharyngeal carcinoma.
New Strategies Explored: Immune Checkpoint Inhibitors in Ovarian Cancer
Study compares sequential vs. combination immunotherapy in platinum-resistant ovarian cancer patients.
Ripretinib Shows Promise in Chinese GIST Patients: Efficacy and Safety Comparable to Sunitinib
Phase 2 trial finds ripretinib effective and safer than sunitinib for advanced GIST in Chinese patients.
Pembrolizumab Boosts Early TNBC Outcomes in Asian Patients: KEYNOTE-522 Subanalysis
Immunotherapy improves pathological complete response and event-free survival in Asian TNBC patients.
New Hope in Lung Cancer: Dostarlimab Rivals Pembrolizumab in First-Line Treatment
Phase II trial shows dostarlimab plus chemo matches pembrolizumab efficacy for metastatic NSCLC patients.
Novel Oral SERD Shows Promise in Early-Stage Breast Cancer Study
Amcenestrant demonstrates antiproliferative effects and ER degradation in ER+/HER2- breast cancer patients.
FLAURA2 Trial: Osimertinib Plus Chemo Boosts Survival in EGFR-Mutated Lung Cancer
Combining osimertinib with chemotherapy significantly improves progression-free survival in NSCLC patients.
Vitamin D Deficiency Linked to Increased Chemotherapy Side Effects in Breast Cancer Patients
Study finds vitamin D insufficiency may raise risk of chemotherapy-induced neuropathy in breast cancer.
New Bladder Cancer Treatment Slashes Recurrence Rates: Promising Results from Egyptian Trial
Study shows neoadjuvant EMDA of mitomycin C before TURBT may reduce bladder cancer recurrence vs BCG alone.